Adlyxin™ (lixisenatide) – New drug approval
July 28, 2016 – The FDA announced the approval of Sanofi and Zealand Pharma’s Adlyxin (lixisenatide) injection, as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus (T2DM).
Download PDF
